Brief: Corline Biomedical Enters Term Sheet Regarding Medical Technology Application
April 12 (Reuters) - CORLINE BIOMEDICAL AB CLBIO.ST :
* ENTERS TERM SHEET REGARDING MEDICAL TECHNOLOGY APPLICATION
* DEAL EXPECTED TO GENERATE REVENUE OF UP TO SEK 50 MILLION
PER
YEAR FOR CORLINE
Source text for Eikon: ID:nGNE1sK2H9
Further company coverage: CLBIO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln